Deutsche Bank’s Kevin McVeigh believes Trueblue Inc TBI shares have “rallied too much,” rising 25 percent since the company lowered its guidance in Q1.
McVeigh initiated coverage of the company with a Sell rating and price target of $20.
Execution Needed
Mentioning that he liked Trueblue’s business model, the analyst noted that “the Street has to become more comfortable with estimates — which we believe need to come down and require management execution — before we are more balanced on the TBI stock.”
McVeigh also believes the company could be one of the first to witness a downturn, although it is also likely to be the first to come out of a downturn, given that Trueblue has peak earnings in 2006.
Closer To Peak
“Our cycle analysis suggests we are closer to the peak than the trough. That said, branches at Trueblue are essentially variable cost due to the ease with which it takes to close them,’ the analyst stated, while adding, “As such, Trueblue can preserve earnings if things get much tougher than we expect.”
Full ratings data available on Benzinga Pro.
Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email feedback@benzinga.com with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.